AlphaStocks

AMPH vs PAHC

As of Sep 20, 2026, Amphastar Pharmaceuticals (AMPH) scores 7.5/10 and Phibro Animal Health (PAHC) 1.7/10 on AlphaStocks' five-model composite, so AMPH scores higher. PAHC trades 31% above its model fair value.

AMPH

Amphastar Pharmaceuticals, Inc.

7.5

Strong Buy

$23.60

PAHC

PHIBRO ANIMAL HEALTH CORP

1.7

Avoid

$34.62

AMPH vs PAHC: Which is the Better Investment?

Amphastar Pharmaceuticals, Inc. (AMPH) scores 7.5/10 while PHIBRO ANIMAL HEALTH CORP (PAHC) scores 1.7/10 on AlphaStocks' composite model. Amphastar Pharmaceuticals, Inc. has the higher composite rating of Strong Buy.

This comparison is algorithmically generated and is not financial advice.

MetricAMPHPAHC
Scores & Fundamentals
Composite Score7.5/101.7/10
RatingStrong BuyAvoid
Price$23.60$34.62
P/E Ratio29.2
ROE17.5%
Market Cap$1B$1B
Fair Value$26.47
Dividend Yield1.5%
Sector Rank#4 of 168#165 of 168
Model Verdicts
PiotroskiAttractiveAttractive
BuffettAttractiveCaution
GrahamAttractiveNeutral
LynchAttractiveCaution
GreenblattAttractiveNeutral
View full AMPHanalysis →View full PAHCanalysis →

Related comparisons

Compare any two stocks →

AMPH vs PAHC: Which Stock Scores Higher?

Amphastar Pharmaceuticals, Inc. (AMPH) and PHIBRO ANIMAL HEALTH CORP (PAHC) are both in the Health Care sector. AMPH currently leads with a composite score of 7.5/10 (Strong Buy) compared to PAHC's 1.7/10 (Avoid).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer